- cafead Jun 12, 2024 at 12:02: PM
via GSK and Ochre Bio will work together in a $37.5 million partnership to pinpoint the drivers of liver disease.
The new partnership, announced Wednesday morning, will see GSK access Ochre’s computational biology, cellular and perfused human organ platforms to generate human liver data sets that can be used to better understand the biology of the liver.
article source
The new partnership, announced Wednesday morning, will see GSK access Ochre’s computational biology, cellular and perfused human organ platforms to generate human liver data sets that can be used to better understand the biology of the liver.
article source